Lv1
48 积分 2024-10-22 加入
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
26天前
已完结
Adopting GPR75 in treating obesity: unraveling the knowns and unknowns of this orphan GPCR
1个月前
已完结
Multiple sclerosis research in 2025: earlier diagnosis and halting progression
1个月前
已完结
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
1个月前
已完结
B cells in multiple sclerosis — from targeted depletion to immune reconstitution therapies
1个月前
已完结
Tissue-resident immune cells in the pathogenesis of multiple sclerosis
1个月前
已完结
Prevalence and Impact of Bypassing or Overriding Phase 2 Trials in Neurologic Drug Development
2个月前
已完结
From development to clinical success: the journey of established and next-generation BTK inhibitors
2个月前
已完结
Autoimmune encephalitis
2个月前
已完结
Autoimmune encephalitis
2个月前
已完结
皖公网安备34019202002308
